Xuejing Yang

Also affiliated with Memorial Sloan Kettering Cancer Center, University of Electronic Science and Technology of China, Hebei University of Science and Technology, Kettering University

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma”.

TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma

Nature Communications(2022)10.1038/s41467-022-33137-8

N/A

0.510DataRank · unranked

29 citations

Chiara M. Evans, Daniel Zakheim, Eren L. Chu, Alice Yunsi Refermat, Zahra Asgari +18 more

SON is an essential m6A target for hematopoietic stem cell fate

Cell stem cell(2023)10.1016/j.stem.2023.11.006

N/A

0.442DataRank · unranked

18 citations

Mariela Cortés-López, Cyrus L. Tam, Michael Xiao, Isaac Wakiro, Karen L. Chu +11 more